Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test

Devyser Diagnostics AB has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is valid for a period of up to four years. Indicative order value is estimated to be approximately SEK 2.5 million annually.